Fulc investor alert: bronstein, gewirtz and grossman, llc announces an investigation into fulcrum therapeutics, inc. and encourages investors to contact the firm!

New york--(business wire)---- $fulc #classaction--attorney advertising--bronstein, gewirtz & grossman, llc is investigating potential claims on behalf of purchasers of fulcrum therapeutics, inc. (“fulcrum” or “the company”) (nasdaq: fulc). investors who purchased fulcrum securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/fulc. investigation details on september 12, 2024, fulcrum announced that “its phase 3 reach trial evaluating losmapim.
FULC Ratings Summary
FULC Quant Ranking